These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 4005848)
1. S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level. Smets LA; Homan-Blok J Cancer Res; 1985 Jul; 45(7):3113-7. PubMed ID: 4005848 [TBL] [Abstract][Full Text] [Related]
2. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells. Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533 [TBL] [Abstract][Full Text] [Related]
3. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor. Fietkau R; Friede H; Maurer-Schultze B Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of dexamethasone restricted to noncycling, early G1-phase cells of L1210 leukemia. Smets LA; Bout B; Brouwer M; Tulp A J Cell Physiol; 1983 Sep; 116(3):397-403. PubMed ID: 6885934 [TBL] [Abstract][Full Text] [Related]
5. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system. Raymakers RA; Slocum HK; Minderman H; Malmberg M; Rustum YM Exp Hematol; 1993 May; 21(5):602-7. PubMed ID: 8513859 [TBL] [Abstract][Full Text] [Related]
6. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo. Chou TC; Hutchinson DJ; Schmid FA; Philips FS Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791 [TBL] [Abstract][Full Text] [Related]
7. Flow microfluorometric analysis of the cell cycle phase cytotoxicity of ARA-C. Hromas RA; Markel DE; Scholes VE Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):365-8. PubMed ID: 7444164 [TBL] [Abstract][Full Text] [Related]
8. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia. Colly LP; Peters WG; Willemze R Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691 [TBL] [Abstract][Full Text] [Related]
9. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells. Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine. Pallavicini MG; Gray JW; Folstad LJ Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956 [TBL] [Abstract][Full Text] [Related]
11. Flow microfluorimetric analysis of sensitive and resistant leukemia L1210 following 1-beta-D-arabinofuranosylcytosine in vivo. Alabaster O; Bunnag B Cancer Res; 1976 Aug; 36(8):2744-9. PubMed ID: 1277184 [TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis. Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells. Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999 [TBL] [Abstract][Full Text] [Related]
14. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy. Moran RE; Straus MJ Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059 [TBL] [Abstract][Full Text] [Related]
15. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate. Liliemark JO; Plunkett W Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676 [TBL] [Abstract][Full Text] [Related]
16. Effect of tetrahydrouridine on the action of 1-beta-D-arabinofuranosylcytosine in synchronized cultures of normal rat kidney cells. Wan CW; Mak TW Cancer Res; 1979 Oct; 39(10):3981-5. PubMed ID: 476637 [TBL] [Abstract][Full Text] [Related]
17. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells. Traganos F; Darzynkiewicz Z; Melamed MR Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341 [TBL] [Abstract][Full Text] [Related]
18. Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinations. Bhuyan BK; Blowers CL; Neil GL; Bono VH; Day KJ Cancer Res; 1977 Sep; 37(9):3204-8. PubMed ID: 560250 [TBL] [Abstract][Full Text] [Related]
19. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670 [TBL] [Abstract][Full Text] [Related]
20. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells. Bhuyan BK; Fraser TJ; Day KJ Cancer Res; 1977 Apr; 37(4):1057-63. PubMed ID: 139202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]